Navigation Links
Probing the mechanism of ADAM28-mediated cancer metastasis
Date:6/8/2012

ADAM28, a metalloproteinase belonging to the ADAM gene family, cleaves the von Willebrand factor (VWF) and inhibits VWF-mediated cancer cell apoptosis, thereby enhancing lung metastases, so inhibiting its expression gives a substantial reduction in lung metastases, according to a study published June 8 in the Journal of The National Cancer Institute.

Several ADAMs are known to be found in tumors and are linked with both tumor growth and cancer progression in humans. While ADAM28 is overexpressed in both breast and non-small cell lung cancers, the mechanism of ADAM28-mediated metastasis is unknown.

In order to search for substrates of ADAM28, Satsuki Mochizuki, Ph.D., of the Department of Pathology at the School of Medicine at Keio University in Japan, and colleagues screened a human lung cDNA library for ADAM28-binding proteins by a yeast two-hybrid system, and identified VWF as a candidate. ADAM28's effect on VWF-induced apoptosis was measured in various human cancer cell lines, while the effect of its inhibition on lung metastases of human lung cancer and breast cancer cells was investigated in mouse models.

The researchers found that inhibition of ADAM28 expression or activity showed a substantial reduction in lung metastases and increased apoptosis of cancer cells in blood vessels. "Our data in this study have demonstrated that VWF induces apoptosis in many human cell lines established from carcinomas of the lung, breast, kidney, and liver only when they have very low-level expression of ADAM28 or when the activity and/or expression are knocked down," the researchers write. The researchers note the limitations of the study, however, namely that the model doesn't reflect the spontaneous metastatic process of human cancers that involves invading carcinoma cells from the primary tumors during a long period of time. Still they feel that, "the results suggest that ADAM28 has dual promoting effects on carcinoma cell proliferation and spontaneous metastasis to distant organs."

In an accompanying editorial, Stanley Zucker, M.D. and Jian Cao, M.D., of the Department of Medicine at Veterans Affairs Medical Center in Northport, New York, write that the study opens the door to many other questions regarding the metastatic process. For example, they write, "An association of VWF levels in blood and tissues and ADAM28 levels in patients' tumor tissue with indolent versus aggressive cancers would be revealing." They also point out that the fact that mouse lung metastases occur within weeks, but human metastases over years is cause for concern.

The researchers also pose the question of whether a small number of driver genes will be identified in the metastatic process, or individual human tumors will require different proteins to complete the metastatic process. They write, "We have the cell and molecular technology, animal models, and clinical tools to solve the problem, but the path to drug discovery for treatment of metastasis and the dream of turning cancer into a "chronic disease" might turn the dream into an obstacle."


'/>"/>

Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Study supports urate protection against Parkinsons disease, hints at novel mechanism
2. Aggregating instead of stabilizing: New insights into the mechanisms of heart disease
3. Researchers gain better understanding of mechanism behind tau spreading in the brain
4. Joslin scientists identify important mechanism that affects the aging process
5. Moffitt Cancer Center researchers develop and test new anti-cancer vaccine
6. Study sheds new light on role of genetic mutations in colon cancer development
7. Child CT Scans Might Up Risk of Brain Cancer, Leukemia
8. 2-1-1 could be effective tool in fighting cancer disparities
9. Researchers at IRB Barcelona uncover new clues about the origin of cancer
10. Nanomedicines promise fewer side effects in treating cancer
11. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
Breaking Medicine Technology: